Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics
Pharmaceuticals · 28.03.2023 · 16 (4) · 504
DOI: 10.3390/ph16040504 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 28.03.2023. Verfasst von Meyammai Shanmugham und 2 weiteren Autor:innen. Beteiligte Einrichtung: Science, Math & Technology, Singapore University of Technology & Design, 8 Somapah Road, Singapore 487372, Singapore. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SUTD Start-up Research Grant, SUTD-ZJU Grant, SUTD Kickstarter Initiative.
Abstract (Originalsprache)
Trimethylamine N-oxide (TMAO) is a biologically active gut microbiome-derived dietary metabolite. Recent studies have shown that high circulating plasma TMAO levels are closely associated with diseases such as atherosclerosis and hypertension, and metabolic disorders such as diabetes and hyperlipidemia, contributing to endothelial dysfunction. There is a growing interest to understand the mechanisms underlying TMAO-induced endothelial dysfunction in cardio-metabolic diseases. Endothelial dysfunction mediated by TMAO is mainly driven by inflammation and oxidative stress, which includes: (1) activation of foam cells; (2) upregulation of cytokines and adhesion molecules; (3) increased production of reactive oxygen species (ROS); (4) platelet hyperreactivity; and (5) reduced vascular tone. In this review, we summarize the potential roles of TMAO in inducing endothelial dysfunction and the mechanisms leading to the pathogenesis and progression of associated disease conditions. We also discuss the potential therapeutic strategies for the treatment of TMAO-induced endothelial dysfunction in cardio-metabolic diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Science, Math & Technology, Singapore University of Technology & Design, 8 Somapah Road, Singapore 487372, Singapore.
- A*STAR Skin Research Labs, Agency for Science, Technology and Research, Singapore 138648, Singapore.
ORCID-Profile: Meyammai Shanmugham, Sophie Bellanger, Chen Huei Leo
Förderung
- SUTD Start-up Research Grant
- SUTD-ZJU Grant
- SUTD Kickstarter Initiative
Zitieren
APA
Shanmugham, M., Bellanger, S., & Leo, C. H. (2023). Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics. Pharmaceuticals, 16(4), 504. https://doi.org/10.3390/ph16040504
Vancouver
Shanmugham M, Bellanger S, Leo CH. Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics. Pharmaceuticals. 2023;16(4):504. doi:10.3390/ph16040504
BibTeX
@article{Shanmugham2023,
author = {Shanmugham, Meyammai and Bellanger, Sophie and Leo, Chen Huei},
title = {Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {4},
pages = {504},
doi = {10.3390/ph16040504}
}
EUVIMED